ロード中...
Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
Clinical trials have demonstrated that an increased number of effector cells, especially tumor-specific T cells, is positively linked with patients’ prognosis. Although the discovery of checkpoint inhibitors (CPIs) has led to encouraging progress in cancer immunotherapy, the lack of either T cells o...
保存先:
| 出版年: | BMB Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Society for Biochemistry and Molecular Biology
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7851446/ https://ncbi.nlm.nih.gov/pubmed/33407991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2021.54.1.257 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|